We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGA icon
76
Reinsurance Group of America
RGA
$15.7B
$33.7M 0.45%
262,500
+22,200
+9% +$2.8M
HUBS icon
77
HubSpot
HUBS
$10.5B
$33.6M 0.45%
510,695
– –
RHT
78
DELISTED
Red Hat Inc
RHT
$33.4M 0.45%
348,581
+9,500
+3% +$848K
NVDA icon
79
NVIDIA
NVDA
$5.01T
$33M 0.44%
9,142,560
+2,033,920
+29% +$6.46M
LLY icon
80
Eli Lilly
LLY
$1.07T
$32.9M 0.44%
400,000
-40,000
-9% -$3.26M
XLRN
81
DELISTED
Acceleron Pharma
XLRN
$32.7M 0.44%
1,075,000
+325,000
+43% +$9.42M
BOX icon
82
Box
BOX
$4.02B
$32.7M 0.44%
1,790,490
+663,100
+59% +$12M
AGCO icon
83
AGCO
AGCO
$8.78B
$31.9M 0.43%
473,809
– –
AKAO
84
DELISTED
Achaogen Inc
AKAO
$31.7M 0.43%
1,460,496
+179,525
+14% +$4.1M
NTES icon
85
NetEase
NTES
$76.5B
$31.5M 0.42%
524,275
-32,440
-6% -$1.86M
RNR icon
86
RenaissanceRe
RNR
$13.7B
$31.2M 0.42%
224,300
+7,200
+3% +$1.01M
BAH icon
87
Booz Allen Hamilton
BAH
$8.7B
$31.2M 0.42%
957,718
– –
ANET icon
88
Arista Networks
ANET
$219B
$31M 0.42%
3,316,800
-461,344
-12% -$4.18M
CGNX icon
89
Cognex
CGNX
$10.3B
$30.3M 0.41%
713,912
+354,820
+99% +$15.8M
NOW icon
90
ServiceNow
NOW
$102B
$30.3M 0.41%
1,428,400
-136,175
-9% -$2.67M
ABMD
91
DELISTED
Abiomed Inc
ABMD
$30.1M 0.41%
210,000
-18,000
-8% -$2.42M
LOXO
92
DELISTED
Loxo Oncology, Inc
LOXO
$29.7M 0.4%
370,000
+69,785
+23% +$3.87M
ICLR icon
93
Icon
ICLR
$12.8B
$29.5M 0.4%
302,045
-157,383
-34% -$13.9M
AMG icon
94
Affiliated Managers Group
AMG
$9.46B
$29.4M 0.4%
177,232
– –
EA icon
95
Electronic Arts
EA
$52.4B
$27.9M 0.38%
264,168
-98,540
-27% -$10.1M
AXON
96
Axon Enterprise
AXON
$40.5B
$27.8M 0.37%
1,105,875
+87,495
+9% +$2.14M
PEN icon
97
Penumbra
PEN
$12.5B
$27.5M 0.37%
313,630
– –
TRV icon
98
Travelers Companies
TRV
$80.8B
$27.5M 0.37%
217,050
+6,950
+3% +$855K
EW icon
99
Edwards Lifesciences
EW
$47.6B
$27.2M 0.37%
+690,000
New +$25.2M
NUVA
100
DELISTED
NuVasive, Inc.
NUVA
$26.9M 0.36%
+350,000
New +$26.2M
2 3
4
5 6

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.